<p>AllianceBernstein（纽约证券交易所代码：AB - 获取免费报告）在周三发布的研究报告中，巴克莱的股票研究分析师将其目标价格从 34.00 美元上调至 36.00 美元。该公司目前对这家资产管理公司的股票给予 “持平” 评级。巴克莱的目标价格暗示该公司当前价格有 3.05% 的下行潜力。</p>
<p>获取 <strong>AllianceBernstein</strong> 的提醒：</p>
<ul>
<li>3 只逆势而上的生物制药股票</li>
</ul>
<p>其他几家券商最近也对 AB 发布了报告。Evercore ISI 将 AllianceBernstein 的目标价格从 41.00 美元下调至 38.00 美元，并在 4 月 11 日的研究报告中给予该公司 “跑赢大盘” 的评级。美国银行将 AllianceBernstein 的股票评级从 “买入” 下调至 “中性”，并在 4 月 3 日的研究报告中将该公司的目标价格从 42.00 美元下调至 38.00 美元。Sanford C. Bernstein 在 4 月 3 日的报告中将 AllianceBernstein 的股票评级从 “买入” 下调至 “中性”，并设定了 38.00 美元的目标价格。最后，TD Cowen 在 4 月 9 日的报告中将 AllianceBernstein 的目标价格从 37.50 美元下调至 34.00 美元，并对该股票给予 “持有” 评级。四位研究分析师对该股票给予了持有评级，两位分析师对该公司给予了买入评级。根据 MarketBeat.com 的数据，该公司的平均评级为 “持有”，平均目标价格为 37.50 美元。</p>
<p><strong>阅读我们关于 AllianceBernstein 的最新研究报告</strong></p>
<h2>AllianceBernstein 股价下跌 1.7%</h2>
<ul>
<li>MarketBeat 周报 – 03/24 - 03/28</li>
</ul>
<p>AB 的股票在周三开盘价为 37.13 美元。AllianceBernstein 的 1 年最低价为 30.57 美元，1 年最高价为 41.37 美元。该公司的市值为 41 亿美元，市盈率为 9.98，市盈增长比率为 0.78，贝塔值为 0.97。该公司的 50 日移动平均价格为 36.99 美元，200 日移动平均价格为 36.94 美元。</p>
<p>AllianceBernstein（纽约证券交易所代码：AB - 获取免费报告）最近在 2 月 6 日发布了季度财报。该资产管理公司报告季度每股收益为 1.05 美元，超出市场共识预期的 0.87 美元，超出幅度为 0.18 美元。AllianceBernstein 的净利润率为 9.46%，股本回报率为 17.88%。研究分析师平均预测 AllianceBernstein 在当前年度的每股收益为 3.58 美元。</p>
<h2>AllianceBernstein 的机构交易</h2>
<ul>
<li>AbbVie 股票通过进入减肥市场提升投资组合</li>
</ul>
<p>一些对冲基金最近调整了对该公司的持股。FMR LLC 在第四季度将其在 AllianceBernstein 的持股增加了 19.0%。FMR LLC 目前拥有 3,110,304 股该资产管理公司的股票，价值 115,361,000 美元，此前在该期间内增持了 496,923 股。American Century Companies Inc.在第四季度将其在 AllianceBernstein 的持股增加了 1.1%。American Century Companies Inc.目前拥有 3,026,102 股该资产管理公司的股票，价值 112,238,000 美元，此前在上个季度增持了 33,888 股。摩根大通在第四季度将其在 AllianceBernstein 的持股增加了 18.1%。摩根大通目前拥有 2,899,762 股该资产管理公司的股票，价值 107,552,000 美元，此前在上个季度增持了 445,398 股。Jennison Associates LLC 在第四季度将其在 AllianceBernstein 的持股增加了 7.0%。Jennison Associates LLC 目前拥有 939,649 股该资产管理公司的股票，价值 34,852,000 美元，此前在上个季度增持了 61,326 股。最后，Natixis 在第四季度将其在 AllianceBernstein 的持股增加了 16.4%。Natixis 目前拥有 660,700 股该资产管理公司的股票，价值 24,505,000 美元，此前在该期间内增持了 93,300 股。机构投资者持有该公司 19.25% 的股票。</p>
<h2>关于 AllianceBernstein</h2>
<p>（获取免费报告）</p>
<p>AllianceBernstein Holding L.P.是一家公开上市的投资管理公司。该公司是相关顾问，管理着为客户量身定制的独立投资组合。该公司主要投资于普通股和优先股、认股权证和可转换证券、政府和企业固定收益证券、商品、货币、房地产相关资产和通胀保护证券。</p>
<h2>精选文章</h2>
<ul>
<li>五只我们更看好的股票比 AllianceBernstein 更好</li>
<li>什么是股息竞争者？投资股息竞争者</li>
<li>3 家高价值公司具有三位数的上涨潜力</li>
<li>期权交易 - 理解行使价格</li>
<li>强生的收益好于坏——现在是买入的时候吗？</li>
<li>三只值得买入和持有的医疗保健股息股票</li>
<li>今年迄今表现最差的两只标准普尔 500 股票：买入、卖出还是回避？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUFC?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUFC"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前经过 MarketBeat 编辑团队的审核。如对该故事有任何问题或意见，请发送电子邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 AllianceBernstein 吗？</h2>
<p>在考虑 AllianceBernstein 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前买入……而 AllianceBernstein 并不在名单上。</p>
<p>虽然 AllianceBernstein 目前在分析师中获得 “持有” 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

<p>巴克莱将 AllianceBernstein（纽约证券交易所代码：AB）的目标价从 34.00 美元上调至 36.00 美元，维持 “持平” 评级。这意味着相较于当前价格，存在 3.05% 的潜在下行空间。其他券商也调整了他们的评级，Evercore ISI 设定的目标价为 38.00 美元，而美国银行也将其目标价下调至 38.00 美元。AllianceBernstein 的股票开盘价为 37.13 美元，1 年区间为 30.57 美元至 41.37 美元。分析师预测当前年的每股收益为 3.58 美元</p>

<p>AllianceBernstein (NYSE:AB - Get Free Report) had its price objective boosted by equities research analysts at Barclays from $34.00 to $36.00 in a research note issued on Wednesday,Benzinga reports. The firm presently has an &#34;equal weight&#34; rating on the asset manager's stock. Barclays's price target suggests a potential downside of 3.05% from the company's current price.</p>
<div class="lb-trans"><p>AllianceBernstein（纽约证券交易所代码：AB - 获取免费报告）在周三发布的研究报告中，巴克莱的股票研究分析师将其目标价格从 34.00 美元上调至 36.00 美元。该公司目前对这家资产管理公司的股票给予 “持平” 评级。巴克莱的目标价格暗示该公司当前价格有 3.05% 的下行潜力。</p>
</div><p>Get <strong>AllianceBernstein</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>AllianceBernstein</strong> 的提醒：</p>
</div><ul>
<li>3 Biopharmaceutical Stocks Bucking the Sell-Off</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只逆势而上的生物制药股票</li>
</ul>
</div><p>Several other brokerages also recently issued reports on AB. Evercore ISI reduced their price objective on AllianceBernstein from $41.00 to $38.00 and set an &#34;outperform&#34; rating for the company in a research note on Friday, April 11th. Bank of America lowered shares of AllianceBernstein from a &#34;buy&#34; rating to a &#34;neutral&#34; rating and dropped their price objective for the company from $42.00 to $38.00 in a research note on Thursday, April 3rd. Sanford C. Bernstein cut shares of AllianceBernstein from a &#34;buy&#34; rating to a &#34;neutral&#34; rating and set a $38.00 price objective for the company. in a report on Thursday, April 3rd. Finally, TD Cowen lowered their price objective on AllianceBernstein from $37.50 to $34.00 and set a &#34;hold&#34; rating on the stock in a report on Wednesday, April 9th. Four research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, the company has an average rating of &#34;Hold&#34; and an average price target of $37.50.</p>
<div class="lb-trans"><p>其他几家券商最近也对 AB 发布了报告。Evercore ISI 将 AllianceBernstein 的目标价格从 41.00 美元下调至 38.00 美元，并在 4 月 11 日的研究报告中给予该公司 “跑赢大盘” 的评级。美国银行将 AllianceBernstein 的股票评级从 “买入” 下调至 “中性”，并在 4 月 3 日的研究报告中将该公司的目标价格从 42.00 美元下调至 38.00 美元。Sanford C. Bernstein 在 4 月 3 日的报告中将 AllianceBernstein 的股票评级从 “买入” 下调至 “中性”，并设定了 38.00 美元的目标价格。最后，TD Cowen 在 4 月 9 日的报告中将 AllianceBernstein 的目标价格从 37.50 美元下调至 34.00 美元，并对该股票给予 “持有” 评级。四位研究分析师对该股票给予了持有评级，两位分析师对该公司给予了买入评级。根据 MarketBeat.com 的数据，该公司的平均评级为 “持有”，平均目标价格为 37.50 美元。</p>
</div><p><strong>Read Our Latest Research Report on AllianceBernstein</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于 AllianceBernstein 的最新研究报告</strong></p>
</div><h2>AllianceBernstein Trading Down 1.7 %</h2>
<div class="lb-trans"><h2>AllianceBernstein 股价下跌 1.7%</h2>
</div><ul>
<li>MarketBeat Week in Review – 03/24 - 03/28</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周报 – 03/24 - 03/28</li>
</ul>
</div><p>Shares of AB opened at $37.13 on Wednesday. AllianceBernstein has a 1-year low of $30.57 and a 1-year high of $41.37. The stock has a market capitalization of $4.10 billion, a P/E ratio of 9.98, a P/E/G ratio of 0.78 and a beta of 0.97. The business's 50-day moving average price is $36.99 and its 200 day moving average price is $36.94.</p>
<div class="lb-trans"><p>AB 的股票在周三开盘价为 37.13 美元。AllianceBernstein 的 1 年最低价为 30.57 美元，1 年最高价为 41.37 美元。该公司的市值为 41 亿美元，市盈率为 9.98，市盈增长比率为 0.78，贝塔值为 0.97。该公司的 50 日移动平均价格为 36.99 美元，200 日移动平均价格为 36.94 美元。</p>
</div><p>AllianceBernstein (NYSE:AB - Get Free Report) last issued its quarterly earnings results on Thursday, February 6th. The asset manager reported $1.05 EPS for the quarter, beating the consensus estimate of $0.87 by $0.18. AllianceBernstein had a net margin of 9.46% and a return on equity of 17.88%. On average, research analysts predict that AllianceBernstein will post 3.58 earnings per share for the current year.</p>
<div class="lb-trans"><p>AllianceBernstein（纽约证券交易所代码：AB - 获取免费报告）最近在 2 月 6 日发布了季度财报。该资产管理公司报告季度每股收益为 1.05 美元，超出市场共识预期的 0.87 美元，超出幅度为 0.18 美元。AllianceBernstein 的净利润率为 9.46%，股本回报率为 17.88%。研究分析师平均预测 AllianceBernstein 在当前年度的每股收益为 3.58 美元。</p>
</div><h2>Institutional Trading of AllianceBernstein</h2>
<div class="lb-trans"><h2>AllianceBernstein 的机构交易</h2>
</div><ul>
<li>AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market</li>
</ul>
<div class="lb-trans"><ul>
<li>AbbVie 股票通过进入减肥市场提升投资组合</li>
</ul>
</div><p>A number of hedge funds have recently modified their holdings of the company. FMR LLC lifted its holdings in shares of AllianceBernstein by 19.0% during the 4th quarter. FMR LLC now owns 3,110,304 shares of the asset manager's stock worth $115,361,000 after acquiring an additional 496,923 shares during the period. American Century Companies Inc. boosted its holdings in AllianceBernstein by 1.1% during the fourth quarter. American Century Companies Inc. now owns 3,026,102 shares of the asset manager's stock valued at $112,238,000 after purchasing an additional 33,888 shares in the last quarter. JPMorgan Chase &amp; Co. raised its holdings in shares of AllianceBernstein by 18.1% in the 4th quarter. JPMorgan Chase &amp; Co. now owns 2,899,762 shares of the asset manager's stock worth $107,552,000 after buying an additional 445,398 shares in the last quarter. Jennison Associates LLC boosted its stake in AllianceBernstein by 7.0% in the 4th quarter. Jennison Associates LLC now owns 939,649 shares of the asset manager's stock valued at $34,852,000 after buying an additional 61,326 shares in the last quarter. Finally, Natixis grew its position in AllianceBernstein by 16.4% in the fourth quarter. Natixis now owns 660,700 shares of the asset manager's stock valued at $24,505,000 after acquiring an additional 93,300 shares during the period. Institutional investors own 19.25% of the company's stock.</p>
<div class="lb-trans"><p>一些对冲基金最近调整了对该公司的持股。FMR LLC 在第四季度将其在 AllianceBernstein 的持股增加了 19.0%。FMR LLC 目前拥有 3,110,304 股该资产管理公司的股票，价值 115,361,000 美元，此前在该期间内增持了 496,923 股。American Century Companies Inc.在第四季度将其在 AllianceBernstein 的持股增加了 1.1%。American Century Companies Inc.目前拥有 3,026,102 股该资产管理公司的股票，价值 112,238,000 美元，此前在上个季度增持了 33,888 股。摩根大通在第四季度将其在 AllianceBernstein 的持股增加了 18.1%。摩根大通目前拥有 2,899,762 股该资产管理公司的股票，价值 107,552,000 美元，此前在上个季度增持了 445,398 股。Jennison Associates LLC 在第四季度将其在 AllianceBernstein 的持股增加了 7.0%。Jennison Associates LLC 目前拥有 939,649 股该资产管理公司的股票，价值 34,852,000 美元，此前在上个季度增持了 61,326 股。最后，Natixis 在第四季度将其在 AllianceBernstein 的持股增加了 16.4%。Natixis 目前拥有 660,700 股该资产管理公司的股票，价值 24,505,000 美元，此前在该期间内增持了 93,300 股。机构投资者持有该公司 19.25% 的股票。</p>
</div><h2>About AllianceBernstein</h2>
<div class="lb-trans"><h2>关于 AllianceBernstein</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>AllianceBernstein Holding L.P. is a publicly owned investment manager. The firm is a related adviser The firm manages separate client focused portfolios for its clients. The firm primarily invests in common and preferred stocks, warrants and convertible securities, government and corporate fxed-income securities, commodities, currencies, real estate-related assets and infation-protected securities.</p>
<div class="lb-trans"><p>AllianceBernstein Holding L.P.是一家公开上市的投资管理公司。该公司是相关顾问，管理着为客户量身定制的独立投资组合。该公司主要投资于普通股和优先股、认股权证和可转换证券、政府和企业固定收益证券、商品、货币、房地产相关资产和通胀保护证券。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than AllianceBernstein</li>
<li>What Are Dividend Contenders? Investing in Dividend Contenders</li>
<li>3 High-Value Companies With Triple-Digit Upside Potential</li>
<li>Options Trading - Understanding Strike Price</li>
<li>Johnson &amp; Johnson Earnings Were More Good Than Bad—Time to Buy?</li>
<li>The Top 3 Healthcare Dividend Stocks to Buy and Hold</li>
<li>The 2 Worst Performing S&amp;P 500 Stocks YTD: Buy, Sell, or Avoid?</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票比 AllianceBernstein 更好</li>
<li>什么是股息竞争者？投资股息竞争者</li>
<li>3 家高价值公司具有三位数的上涨潜力</li>
<li>期权交易 - 理解行使价格</li>
<li>强生的收益好于坏——现在是买入的时候吗？</li>
<li>三只值得买入和持有的医疗保健股息股票</li>
<li>今年迄今表现最差的两只标准普尔 500 股票：买入、卖出还是回避？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUFC" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NYSE&amp;Symbol=AB"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前经过 MarketBeat 编辑团队的审核。如对该故事有任何问题或意见，请发送电子邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in AllianceBernstein Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 AllianceBernstein 吗？</h2>
</div><p>Before you consider AllianceBernstein, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 AllianceBernstein 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AllianceBernstein wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前买入……而 AllianceBernstein 并不在名单上。</p>
</div><p>While AllianceBernstein currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 AllianceBernstein 目前在分析师中获得 “持有” 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

巴克莱分析师表示，AllianceBernstein（纽约证券交易所代码：AB）的股价预计将会上涨